Scanogen Inc.
Scanogen is a molecular diagnostic company focused on developing rapid and ultra-sensitive detection systems for biomolecules in body fluids. Utilizing their proprietary Single MOLecule Tethering (SMOLT) technology, Scanogen aims to improve healthcare by providing quick and actionable diagnostic results, particularly in the areas of bloodstream and respiratory infections.
Scanogen Inc.
Patents
What We Do
A revolutionary platform technology for ultra-sensitive and rapid detection of nucleic acids and microorganisms in body fluids, enabling direct detection in whole blood, saliva, sputum, and urine.
An assay under development for rapid identification of bloodstream pathogens, providing results in 60 minutes without the need for blood culture.
Diagnostics
Infectious Diseases
Biologics
News & Updates
Granted for a novel method to eliminate background noise in assays based on a solid substrate.
Covers the optical system used in SMOLT, including an imaging system to determine the position or movement of particles over a large field of view.
Covers Single Molecule Tethering (SMOLT) technology, including detection of molecules using long probes.